Considerations for developing scalable and efficient collection network processes

Thursday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST

Sponsor

Considerations for developing scalable and efficient collection network processes

This webinar will focus on apheresis center best practices within the allogeneic product collection pathway that help build efficiencies within cell and gene therapy protocols. These best practices ultimately lead to high-quality, therapy-matched starting material for emerging cell and gene therapies.

Many crucial considerations impact a cell and gene therapy developer’s apheresis center selection strategy and ability to efficiently scale processes. Anytime collection processes or protocols differ from those in place at a center, there are likely implications for training, forms and standard operating procedures (SOPs), which can potentially delay a first collection.

Attend this webinar to learn how to avoid variability and maximize quality and scalability throughout the cell therapy supply chain – ultimately improving collections for product manufacturing.

Common protocol decisions cell and gene therapy developers make along the product collection pathway that can impact ability to scale
Specific considerations for collecting starting material for allogeneic cell therapies
Factors for post-collection transport and processing to ensure efficient delivery of starting material to the manufacturer

Lacey Anderson

Senior Manager, Collection Network Management, Be The Match BioTherapies

Sara Butler

Network Liaison, Be The Match BioTherapies

Sara Butler is a Collection Network Liaison for Be The Match BioTherapies. She serves as a liaison between Be The Match BioTherapies stakeholders, clients and network centers. Sara also provides technical expertise and consultation to improve operational processes and Be The Match BioTherapies product quality. Sara brings to Be The Match BioTherapies nearly a decade of cell therapy experience and knowledge of the industry. She holds a Bachelor’s degree in Biological Science

Allison Montalvo

Program Manager, Oncology, Janssen ( A division of J&J)

Allison Montalvo is currently a Program Manager at Janssen ( A division of J&J) in Oncology. She has over 25 years’ experience in Biotech and Pharmaceutical Drug development (Merck, Teva, Tmunity and now Janssen). Prior to coming to Janssen, Allison was the Head of Project Management and Clinical Supplies at Tmunity. There, she led and developed integrated solutions for end to end supply chain management of CART trials.
Photos are in webinar folder